Jessica M. Grindheim
Papers
1
Total Citations
35
H-Index
1
About
Jessica M. Grindheim is a leading translational researcher in oncology, specializing in liquid biopsy biomarkers and immunotherapy response in non-small cell lung cancer (NSCLC). Her work focuses on harnessing dynamic circulating tumor DNA (ctDNA) to predict and monitor treatment outcomes, particularly in neoadjuvant settings. Her most-cited study, published in 2021, demonstrated that ctDNA dynamics during neoadjuvant atezolizumab therapy and surgery correlate with patient outcomes, providing a non-invasive tool to guide personalized treatment. This landmark work, with 35 citations, has advanced the understanding of real-time tumor evolution and immune checkpoint blockade efficacy. Grindheim’s contributions bridge molecular biology and clinical practice, offering a pathway to earlier intervention and improved survival. Her research is widely recognized for its potential to reduce unnecessary surgeries and optimize drug regimens, making her a key figure in the push toward precision oncology.
Research Focus
Key Achievements
Top Papers
- 1